UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,424,000 | +91.6% | 130,000 | +85.7% | 0.79% | +97.5% |
| Q1 2022 | $1,265,000 | +1.6% | 70,000 | +73.3% | 0.40% | -23.2% |
| Q2 2021 | $1,245,000 | -58.9% | 40,403 | -55.1% | 0.52% | -59.0% |
| Q1 2021 | $3,032,000 | +29.1% | 90,000 | +38.5% | 1.26% | +6.7% |
| Q4 2020 | $2,349,000 | -37.3% | 65,000 | -36.1% | 1.18% | -44.6% |
| Q3 2020 | $3,748,000 | +18.8% | 101,766 | +45.4% | 2.14% | +1.4% |
| Q2 2020 | $3,154,000 | -3.3% | 70,000 | -45.1% | 2.11% | -51.7% |
| Q1 2020 | $3,263,000 | -78.7% | 127,500 | -30.7% | 4.36% | +88.7% |
| Q4 2019 | $15,337,000 | – | 183,997 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |